Teleflex Incorporated announced that it has completed the acquisition of substantially all of the Vascular Intervention ...

Basis Medical announced the completion of the first-in-human clinical procedures using the company’s Seclusion catheter to t ...

BioStem Technologies, Inc., a developer of placental-derived products for wound care, recently announced that patient ...

The Society for Cardiovascular Angiography & Interventions (SCAI) announced the publication of new, evidence-based clinical ...

Verge Medical announced the acquisition of the RoVo system and its temporary occlusion embolectomy (TOE) technology from 2MG ...

Embolization, Inc., a medical device company based in Boulder, Colorado, announced its nitinol-enhanced device (NED) has ...

StentIt, a Netherlands-based developer of stents with regenerative properties, announced the successful implantation of its resorb ...

Thrombolex, Inc., a developer of treatments for arterial and venous thromboembolic diseases, announced the publication of the resu ...

Vivasure Medical announced that it has received European CE Mark approval for an expanded indication for its fully bioresorbable, ...

Teleflex: Manta Vascular Closure Device Bioresorbable implant: Following the use of 10–20 F device or sheaths (12–25 F OD) 0.035: Indicated for closure of femoral artery access sites while reducing ...

Gore & Associates: Gore Viabahn Endoprosthesis With Heparin Bioactive Surface Nitinol/ePTFE, gold: 6–10: 0.018/0.014 (5–8 mm), 0.035 (5–13 mm) ...

Cook Medical. P.O. Box 489, Bloomington, IN 47402 . PHONE: (800) 457-4500 | FAX: (800) 554-8335 ...